Benzinga's Top Initiations
Analysts at SunTrust Robinson Humphrey initiated coverage on Celgene Corporation (NASDAQ: CELG) with a Buy rating. Celgene shares closed at $116.71 on Wednesday.
Macquarie initiated coverage on Syngenta AG (ADR) (NYSE: SYT) with a Neutral rating. Syngenta shares closed at $75.35 on Wednesday.
Analysts at Evercore ISI Group initiated coverage of McGraw Hill Financial Inc (NYSE: MHFI) with a Buy rating. The target price for McGraw Hill Financial is set to $110. McGraw Hill Financial shares closed at $94.08 on Wednesday.
Analysts at Benchmark initiated coverage on Omnicell, Inc. (NASDAQ: OMCL) with a Buy rating. The target price for Omnicell is set to $33. Omnicell shares closed at $28.32 on Wednesday.
Analysts at Societe Generale initiated coverage on Edgewell Personal Care Co (NYSE: EPC) with a Hold rating. Edgewell Personal Care shares closed at $78.28 on Wednesday.
Oppenheimer initiated coverage on Johnson Controls Inc (NYSE: JCI) with a Outperform rating. Johnson Controls shares closed at $37.34 on Wednesday.
Mizuho Securities initiated coverage of Depomed Inc (NASDAQ: DEPO) with a Neutral rating. The target price for Depomed is set to $19. Depomed shares closed at $17.26 on Wednesday.
H.C. Wainwright initiated coverage on InspireMD Inc (NYSE: NSPR) with a Buy rating. The target price for InspireMD is set to $4. InspireMD shares closed at $0.714 on Wednesday.
Analysts at Piper Jaffray initiated initiated coverage on NBT Bancorp Inc. (NASDAQ: NBTB) with a Neutral rating. The target price for NBT Bancorp is set to $30. NBT Bancorp shares closed at $26.80 on Wednesday.
Analysts at Gabelli & Co initiated coverage on FCB Financial Holdings Inc (NYSE: FCB) with a Buy rating. FCB Financial shares closed at $34.70 on Wednesday.
Latest Ratings for CELG
Date | Firm | Action | From | To |
---|---|---|---|---|
Nov 2019 | Standpoint Research | Downgrades | Buy | Hold |
Nov 2019 | Baird | Downgrades | Outperform | Neutral |
May 2019 | Barclays | Downgrades | Overweight | Equal-Weight |
View More Analyst Ratings for CELG
View the Latest Analyst Ratings
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Top InitiationsInitiation Analyst Ratings